Category: 2019

December | 2019

Cannabics Pharmaceuticals to be present during the J.P. Morgan Healthcare Conference In San Francisco

TEL AVIV, Israel and BETHESDA, Md., Dec. 31, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid med

December | 2019

Cannabics Pharmaceuticals Announces the Appointment of Dr. Yaakov Waksman as Head of Cannabidiol Research

TEL AVIV, Israel and BETHESDA, Maryland, Dec. 5, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid

October | 2019

Cannabics Pharmaceuticals Announces Publication of Clinical Data From Its Sponsored Pilot Study on Controlled Release Capsules, on the Journal of Integrative Cancer Therapies

TEL AVIV, Israel and BETHESDA, Maryland, Oct. 16, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoi

October | 2019

Cannabics Pharmaceuticals Appoints Company’s Founder to Its Board of Directors

TEL AVIV, Israel and BETHESDA, Maryland, Oct. 7, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid

September | 2019

Cannabics Pharmaceuticals to Present Research Data at the 2nd International Cannabinoid Derived Pharmaceuticals Summit in Boston, MA

TEL AVIV, Israel and BETHESDA, Maryland, Sept. 12, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTC-QB: CNBX), a leader in personalized cannabis

June | 2019

Wize Pharma Completes Milestone for Joint Venture With Cannabics Pharmaceuticals; Companies to Develop Cannabinoid Ophthalmic Treatments

HOD HASHARON, Israel, June 28, 2019 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment

June | 2019

Cannabics Pharmaceuticals Appoints Two Independent Directors

TEL AVIV, Israel and BETHESDA, Maryland, June 25, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoi

June | 2019

Cannabics Pharmaceuticals to Participate at the LIFT & Co. Conference in Toronto, Canada

TEL AVIV, Israel and BETHESDA, Maryland, June 4, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid

May | 2019

Cannabics Pharmaceuticals to Participate at the 9th Annual LD Micro Invitational in Bel Air, California Press Release |

TEL AVIV, ISRAEL and BETHESDA, MD / ACCESSWIRE / May 30, 2019 / Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medic

April | 2019

Cannabics Pharmaceuticals Announces Initiation of a Nationwide Clinical Study to Evaluate Antitumor Properties of Cannabinoid Compounds on Primary Cancer Biopsies

TEL AVIV, Israel and BETHESDA, Maryland, April 17, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabi

March | 2019

SodaStream CEO Daniel Birnbaum to Join Seedo Board

TEL AVIV, Israel and BETHESDA, Maryland, March 12, 2019 Cannabics Pharmaceuticals Inc. (OTCQB:CNBX), a leader in personalized cannabinoid medicine foc

March | 2019

Wize Pharma, Inc. Closes Deal to Launch Joint Venture With Cannabics

HOD HASHARON, Israel, March 6, 2019 /PRNewswire/ -- Wize Pharma, Inc. ("Wize Pharma" or the "Company") (OTCQB: WIZP) a clinical-stage biopharmaceutical

March | 2019

Cannabics Pharmaceuticals Closes Agreement With Wize Pharma

BETHESDA, Maryland and TEL AVIV, Israel, March 6, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) a world leader in personalized canna

February | 2019

Cannabics Pharmaceuticals Submits Protocol for an Ex-Vivo Clinical Study on Biopsies and Cannabinoids

TEL AVIV, Israel and BETHESDA, Maryland, Feb. 19, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB:CNBX), a leader in personalized cannabinoid

February | 2019

Cannabics Pharmaceuticals and Wize Pharma to Form Joint Venture to Develop Cannabinoid Based Ophthalmic Therapeutics

BETHESDA, Maryland and TEL AVIV, Israel, Feb. 7, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) a world leader in personalized cannab

February | 2019

Wize Pharma, Inc. Signs Joint Venture With Cannabics, to Research and Develop Cannabinoid Formulations to Treat Ophthalmic Conditions

HOD HASHARON, Israel, Feb. 7, 2019 /PRNewswire/ -- Wize Pharma, Inc. ("Wize Pharma" or the "Company") (OTCQB: WIZP) a clinical-stage biopharmaceutical c

January | 2019

Cannabics Pharmaceuticals Files Four New Provisional Patent Applications for Cannabinoid-Based Drugs and Treatments for Non-Epileptic Seizures and Tremors

TEL AVIV, Israel and BETHESDA, Maryland, Jan. 31, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoi

January | 2019

Cannabics Pharmaceuticals and NewCanna Hub Intend to Collaborate to Manufacture and Market Cannabics’ SR Capsules in Colombia

PR Newswire TEL AVIV, Israel and BETHESDA, Maryland, Jan. 24, 2019 TEL AVIV, Israel and BETHESDA, Maryland, Jan. 24, 2019 /PRNewswire/ -- Cannabic

January | 2019

Cannabics Pharmaceuticals to Co-Sponsor the Canada Cannabis House at the World Economic Forum in Davos

TEL AVIV, Israel and BETHESDA, Maryland, Jan. 22, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoi

January | 2019

Cannabics Pharmaceuticals Converts $1 Million Loan Into Common Shares of Seedo

TEL AVIV, Israel, Jan. 8, 2019 /PRNewswire/ -- Seedo Corp. (OTC: SEDO), a high-tech company providing the world's first fully automated and controlled i

December | 2018

Cannabics Pharmaceuticals Announces New Provisional Patent Application for Personalized Cannabimetic Compositions Modeling and Production

TEL AVIV, Israel and BETHESDA, Maryland, Dec. 26, 2018 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (NASDAQ: CNBX), a world leader in personalized can